Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 randomized double-blind placebo-controlled study of Dimebon in mild-to-moderate Huntington disease
2009-011800-44Phase 3Completed
- Sponsor
- Medivation
- Start
- Jun 2009
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Huntington disease (HD) comparing Dimebon with Placebo (2 arms). Started Jun 2009; status: completed.
02
Drugs
latrepirdine
03
Conditions
Huntington disease (HD)
Beyond the preview
Go deeper on 2009-011800-44.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-011800-44.